Usefulness of Global Longitudinal Strain-Guided Management in Preventing Human Epidermal Growth Factor Receptor 2 (HER2) Inhibitor-Induced Myocardial Damage

Background: Trastuzumab, an anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibody, is a specific first-line treatment for patients with HER2-positive cancers. Cardiac dysfunction is among the most problematic adverse events associated with trastuzumab. Although regular echocardiog...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Kenta, Tamura, Yudai, Taniguchi, Hirohisa, Furukawa, Asuka, Iwasawa, Jin, Yada, Hirotaka, Kawamura, Akio, Tamura, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2022
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638510/
https://www.ncbi.nlm.nih.gov/pubmed/36408358
http://dx.doi.org/10.1253/circrep.CR-22-0094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638510/
https://www.ncbi.nlm.nih.gov/pubmed/36408358
http://dx.doi.org/10.1253/circrep.CR-22-0094

Ejemplares similares